(Q86532062)
Statements
PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer (English)
R Wendel Naumann
Robert L Coleman
Robert A Burger
Edward A Sausville
Elzbieta Kutarska
Sharad A Ghamande
Nashat Y Gabrail
Stephen E Depasquale
Lucy Gilbert
Robert H Gersh
Michael G Teneriello
Wael A Harb
Panagiotis A Konstantinopoulos
Richard T Penson
James T Symanowski
Chandra D Lovejoy
Christopher P Leamon
Richard A Messmann
14 October 2013